BioSpace News Archive

Deals

Cancer-Focused Boundless Bio to Go Public as 2024 IPO Rally Continues

The early-stage oncology startup filed for an initial public offering on Wednesday, seeking funds to help develop its novel cancer therapies targeting extrachromosomal DNA.

March 7, 2024
·
2 min read
·
Tristan Manalac
Policy

Biden Calls for Expanding IRA’s Drug Price Negotiation Program

President Joe Biden has proposed expansions to the Inflation Reduction Act, including an increase in the annual number of prescription drugs that would be subject to price negotiations to 50, up from 20.

March 7, 2024
·
4 min read
·
Tristan Manalac
Policy

FDA Action Alert: Mirum, BMS, Madrigal and More

The FDA’s busy week ahead involves three decision dates for potential industry firsts and a highly anticipated advisory committee meeting for two CAR-T therapies.

March 7, 2024
·
6 min read
·
Tristan Manalac
Drug Development

GSK Advances Blenrep’s Potential Comeback with Second Phase III Win

The antibody-drug conjugate beat the standard of care in second-line multiple myeloma, the company reported on Thursday, as it seeks to get the cancer drug back on the U.S. market.

March 7, 2024
·
2 min read
·
Nick Paul Taylor
Business

Gilead, Merus Ink Potential $1.5B Deal for T-Cell Engagers

Gilead Sciences is partnering with Dutch biotech Merus to find novel dual tumor-associated antigens that target tri-specific antibodies.

March 7, 2024
·
2 min read
·
Tyler Patchen
Drug Delivery

AstraZeneca Invests $827M in UK Footprint, Focuses on Vaccine Manufacturing and R&D

The Anglo-Swedish drugmaker is making the investment to bolster its vaccine manufacturing and research and development capabilities in the U.K.

March 7, 2024
·
2 min read
·
Tristan Manalac
Drug Development

Novo Touts Phase I Data for Next-Generation Obesity Candidate

Novo Nordisk’s early-stage amylin and GLP-1 co-agonist elicited a 13.1% reduction in body weight, with an overall favorable safety profile, the Danish drugmaker reported Thursday at an investor event.

March 7, 2024
·
2 min read
·
Tristan Manalac
Biovica Signs Master Service Agreement for TKa Testing with Leading Pharma Company

Biovica International Biovica, active in blood-based cancer monitoring, has signed a master service agreement with a leading tier-1 pharmaceutical company, enabling Biovica to provide its TKa testing assay and testing services.

March 7, 2024
·
1 min read
Senzime Wins its Largest US Deal to Date from Leading Houston Based University Hospital System

Senzime Senzime, an industry leader in precision-based patient monitoring solutions, announces its largest hospital win to date.

March 7, 2024
·
2 min read
Drug Development

Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US

Immuron Limited is pleased to announce the interim topline results confirming that a single daily dose of Travelan® is effective in prevention of moderate to severe diarrhea following challenge with enterotoxigenic Escherichia coli.

March 7, 2024
·
7 min read